ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mucopolysaccharidosis II Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-36O9796
Home | Market Reports | Health| Pharmacy
Global Mucopolysaccharidosis II Market Insights Forecast to 2028
BUY CHAPTERS

Global Mucopolysaccharidosis II Market Research Report 2025

Code: QYRE-Auto-36O9796
Report
January 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alexion Pharmaceuticals Inc
AngioChem Inc
ArmaGen Inc.
BiOasis Technologies Inc
Green Cross Corporation
Inventiva
JCR Pharmaceuticals Co Ltd
Laboratorios Del Dr Esteve S A
REGENXBIO
Sangamo BioSciences, Inc.
Takeda

Mucopolysaccharidosis II Market

The global market for Mucopolysaccharidosis II was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Mucopolysaccharidosis II is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mucopolysaccharidosis II is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mucopolysaccharidosis II include Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc., Bioasis Technologies Inc., Green Cross Corporation, Inventiva, JCR Pharmaceuticals Co., Ltd., Laboratorios Del Dr. Esteve S.A., RegenxBio Inc., Sangamo BioSciences, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mucopolysaccharidosis II, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mucopolysaccharidosis II.
The Mucopolysaccharidosis II market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mucopolysaccharidosis II market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mucopolysaccharidosis II manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mucopolysaccharidosis II Market Report

Report Metric Details
Report Name Mucopolysaccharidosis II Market
Segment by Type
  • JR-141
  • EGT-301
  • DUOC-01
  • AGT-182
  • JR-032
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Research Center
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc., Bioasis Technologies Inc., Green Cross Corporation, Inventiva, JCR Pharmaceuticals Co., Ltd., Laboratorios Del Dr. Esteve S.A., RegenxBio Inc., Sangamo BioSciences, Inc., Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mucopolysaccharidosis II manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mucopolysaccharidosis II in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Mucopolysaccharidosis II Market report?

Ans: The main players in the Mucopolysaccharidosis II Market are Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc., Bioasis Technologies Inc., Green Cross Corporation, Inventiva, JCR Pharmaceuticals Co., Ltd., Laboratorios Del Dr. Esteve S.A., RegenxBio Inc., Sangamo BioSciences, Inc., Takeda

What are the Application segmentation covered in the Mucopolysaccharidosis II Market report?

Ans: The Applications covered in the Mucopolysaccharidosis II Market report are Hospital, Clinic, Research Center, Others

What are the Type segmentation covered in the Mucopolysaccharidosis II Market report?

Ans: The Types covered in the Mucopolysaccharidosis II Market report are JR-141, EGT-301, DUOC-01, AGT-182, JR-032, Others

Recommended Reports

Rare Disease Therapeutics

Genetic & Metabolic Disorders

Pediatric & Rare Syndromes

1 Mucopolysaccharidosis II Market Overview
1.1 Product Definition
1.2 Mucopolysaccharidosis II by Type
1.2.1 Global Mucopolysaccharidosis II Market Value Comparison by Type (2024 VS 2031)
1.2.2 JR-141
1.2.3 EGT-301
1.2.4 DUOC-01
1.2.5 AGT-182
1.2.6 JR-032
1.2.7 Others
1.3 Mucopolysaccharidosis II by Application
1.3.1 Global Mucopolysaccharidosis II Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.3.5 Others
1.4 Global Mucopolysaccharidosis II Market Size Estimates and Forecasts
1.4.1 Global Mucopolysaccharidosis II Revenue 2020-2031
1.4.2 Global Mucopolysaccharidosis II Sales 2020-2031
1.4.3 Global Mucopolysaccharidosis II Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mucopolysaccharidosis II Market Competition by Manufacturers
2.1 Global Mucopolysaccharidosis II Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mucopolysaccharidosis II Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mucopolysaccharidosis II Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mucopolysaccharidosis II, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mucopolysaccharidosis II, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mucopolysaccharidosis II, Product Type & Application
2.7 Global Key Manufacturers of Mucopolysaccharidosis II, Date of Enter into This Industry
2.8 Global Mucopolysaccharidosis II Market Competitive Situation and Trends
2.8.1 Global Mucopolysaccharidosis II Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mucopolysaccharidosis II Players Market Share by Revenue
2.8.3 Global Mucopolysaccharidosis II Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mucopolysaccharidosis II Market Scenario by Region
3.1 Global Mucopolysaccharidosis II Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mucopolysaccharidosis II Sales by Region: 2020-2031
3.2.1 Global Mucopolysaccharidosis II Sales by Region: 2020-2025
3.2.2 Global Mucopolysaccharidosis II Sales by Region: 2026-2031
3.3 Global Mucopolysaccharidosis II Revenue by Region: 2020-2031
3.3.1 Global Mucopolysaccharidosis II Revenue by Region: 2020-2025
3.3.2 Global Mucopolysaccharidosis II Revenue by Region: 2026-2031
3.4 North America Mucopolysaccharidosis II Market Facts & Figures by Country
3.4.1 North America Mucopolysaccharidosis II Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mucopolysaccharidosis II Sales by Country (2020-2031)
3.4.3 North America Mucopolysaccharidosis II Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mucopolysaccharidosis II Market Facts & Figures by Country
3.5.1 Europe Mucopolysaccharidosis II Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mucopolysaccharidosis II Sales by Country (2020-2031)
3.5.3 Europe Mucopolysaccharidosis II Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mucopolysaccharidosis II Market Facts & Figures by Region
3.6.1 Asia Pacific Mucopolysaccharidosis II Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mucopolysaccharidosis II Sales by Region (2020-2031)
3.6.3 Asia Pacific Mucopolysaccharidosis II Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mucopolysaccharidosis II Market Facts & Figures by Country
3.7.1 Latin America Mucopolysaccharidosis II Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mucopolysaccharidosis II Sales by Country (2020-2031)
3.7.3 Latin America Mucopolysaccharidosis II Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mucopolysaccharidosis II Market Facts & Figures by Country
3.8.1 Middle East and Africa Mucopolysaccharidosis II Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mucopolysaccharidosis II Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mucopolysaccharidosis II Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Mucopolysaccharidosis II Sales by Type (2020-2031)
4.1.1 Global Mucopolysaccharidosis II Sales by Type (2020-2025)
4.1.2 Global Mucopolysaccharidosis II Sales by Type (2026-2031)
4.1.3 Global Mucopolysaccharidosis II Sales Market Share by Type (2020-2031)
4.2 Global Mucopolysaccharidosis II Revenue by Type (2020-2031)
4.2.1 Global Mucopolysaccharidosis II Revenue by Type (2020-2025)
4.2.2 Global Mucopolysaccharidosis II Revenue by Type (2026-2031)
4.2.3 Global Mucopolysaccharidosis II Revenue Market Share by Type (2020-2031)
4.3 Global Mucopolysaccharidosis II Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mucopolysaccharidosis II Sales by Application (2020-2031)
5.1.1 Global Mucopolysaccharidosis II Sales by Application (2020-2025)
5.1.2 Global Mucopolysaccharidosis II Sales by Application (2026-2031)
5.1.3 Global Mucopolysaccharidosis II Sales Market Share by Application (2020-2031)
5.2 Global Mucopolysaccharidosis II Revenue by Application (2020-2031)
5.2.1 Global Mucopolysaccharidosis II Revenue by Application (2020-2025)
5.2.2 Global Mucopolysaccharidosis II Revenue by Application (2026-2031)
5.2.3 Global Mucopolysaccharidosis II Revenue Market Share by Application (2020-2031)
5.3 Global Mucopolysaccharidosis II Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Alexion Pharmaceuticals, Inc.
6.1.1 Alexion Pharmaceuticals, Inc. Company Information
6.1.2 Alexion Pharmaceuticals, Inc. Description and Business Overview
6.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolio
6.1.5 Alexion Pharmaceuticals, Inc. Recent Developments/Updates
6.2 AngioChem Inc.
6.2.1 AngioChem Inc. Company Information
6.2.2 AngioChem Inc. Description and Business Overview
6.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AngioChem Inc. Mucopolysaccharidosis II Product Portfolio
6.2.5 AngioChem Inc. Recent Developments/Updates
6.3 ArmaGen Inc.
6.3.1 ArmaGen Inc. Company Information
6.3.2 ArmaGen Inc. Description and Business Overview
6.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ArmaGen Inc. Mucopolysaccharidosis II Product Portfolio
6.3.5 ArmaGen Inc. Recent Developments/Updates
6.4 Bioasis Technologies Inc.
6.4.1 Bioasis Technologies Inc. Company Information
6.4.2 Bioasis Technologies Inc. Description and Business Overview
6.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolio
6.4.5 Bioasis Technologies Inc. Recent Developments/Updates
6.5 Green Cross Corporation
6.5.1 Green Cross Corporation Company Information
6.5.2 Green Cross Corporation Description and Business Overview
6.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Green Cross Corporation Mucopolysaccharidosis II Product Portfolio
6.5.5 Green Cross Corporation Recent Developments/Updates
6.6 Inventiva
6.6.1 Inventiva Company Information
6.6.2 Inventiva Description and Business Overview
6.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Inventiva Mucopolysaccharidosis II Product Portfolio
6.6.5 Inventiva Recent Developments/Updates
6.7 JCR Pharmaceuticals Co., Ltd.
6.7.1 JCR Pharmaceuticals Co., Ltd. Company Information
6.7.2 JCR Pharmaceuticals Co., Ltd. Description and Business Overview
6.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.7.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolio
6.7.5 JCR Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.8 Laboratorios Del Dr. Esteve S.A.
6.8.1 Laboratorios Del Dr. Esteve S.A. Company Information
6.8.2 Laboratorios Del Dr. Esteve S.A. Description and Business Overview
6.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolio
6.8.5 Laboratorios Del Dr. Esteve S.A. Recent Developments/Updates
6.9 RegenxBio Inc.
6.9.1 RegenxBio Inc. Company Information
6.9.2 RegenxBio Inc. Description and Business Overview
6.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.9.4 RegenxBio Inc. Mucopolysaccharidosis II Product Portfolio
6.9.5 RegenxBio Inc. Recent Developments/Updates
6.10 Sangamo BioSciences, Inc.
6.10.1 Sangamo BioSciences, Inc. Company Information
6.10.2 Sangamo BioSciences, Inc. Description and Business Overview
6.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolio
6.10.5 Sangamo BioSciences, Inc. Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Company Information
6.11.2 Takeda Description and Business Overview
6.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Takeda Mucopolysaccharidosis II Product Portfolio
6.11.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mucopolysaccharidosis II Industry Chain Analysis
7.2 Mucopolysaccharidosis II Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mucopolysaccharidosis II Production Mode & Process Analysis
7.4 Mucopolysaccharidosis II Sales and Marketing
7.4.1 Mucopolysaccharidosis II Sales Channels
7.4.2 Mucopolysaccharidosis II Distributors
7.5 Mucopolysaccharidosis II Customer Analysis
8 Mucopolysaccharidosis II Market Dynamics
8.1 Mucopolysaccharidosis II Industry Trends
8.2 Mucopolysaccharidosis II Market Drivers
8.3 Mucopolysaccharidosis II Market Challenges
8.4 Mucopolysaccharidosis II Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Alexion Pharmaceuticals Inc
AngioChem Inc
ArmaGen Inc.
BiOasis Technologies Inc
Green Cross Corporation
Inventiva
JCR Pharmaceuticals Co Ltd
Laboratorios Del Dr Esteve S A
REGENXBIO
Sangamo BioSciences, Inc.
Takeda
List of Tables
 Table 1. Global Mucopolysaccharidosis II Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mucopolysaccharidosis II Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mucopolysaccharidosis II Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mucopolysaccharidosis II Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Mucopolysaccharidosis II Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mucopolysaccharidosis II Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mucopolysaccharidosis II Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mucopolysaccharidosis II Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mucopolysaccharidosis II, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mucopolysaccharidosis II, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mucopolysaccharidosis II, Product Type & Application
 Table 12. Global Key Manufacturers of Mucopolysaccharidosis II, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mucopolysaccharidosis II by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucopolysaccharidosis II as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mucopolysaccharidosis II Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mucopolysaccharidosis II Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Mucopolysaccharidosis II Sales Market Share by Region (2020-2025)
 Table 19. Global Mucopolysaccharidosis II Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Mucopolysaccharidosis II Sales Market Share by Region (2026-2031)
 Table 21. Global Mucopolysaccharidosis II Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mucopolysaccharidosis II Revenue Market Share by Region (2020-2025)
 Table 23. Global Mucopolysaccharidosis II Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mucopolysaccharidosis II Revenue Market Share by Region (2026-2031)
 Table 25. North America Mucopolysaccharidosis II Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Mucopolysaccharidosis II Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Mucopolysaccharidosis II Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mucopolysaccharidosis II Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mucopolysaccharidosis II Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Mucopolysaccharidosis II Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Mucopolysaccharidosis II Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mucopolysaccharidosis II Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mucopolysaccharidosis II Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mucopolysaccharidosis II Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Mucopolysaccharidosis II Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Mucopolysaccharidosis II Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mucopolysaccharidosis II Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mucopolysaccharidosis II Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Mucopolysaccharidosis II Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Mucopolysaccharidosis II Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mucopolysaccharidosis II Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mucopolysaccharidosis II Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Mucopolysaccharidosis II Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Mucopolysaccharidosis II Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mucopolysaccharidosis II Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mucopolysaccharidosis II Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Mucopolysaccharidosis II Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Mucopolysaccharidosis II Sales Market Share by Type (2020-2025)
 Table 53. Global Mucopolysaccharidosis II Sales Market Share by Type (2026-2031)
 Table 54. Global Mucopolysaccharidosis II Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mucopolysaccharidosis II Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mucopolysaccharidosis II Revenue Market Share by Type (2020-2025)
 Table 57. Global Mucopolysaccharidosis II Revenue Market Share by Type (2026-2031)
 Table 58. Global Mucopolysaccharidosis II Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Mucopolysaccharidosis II Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Mucopolysaccharidosis II Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Mucopolysaccharidosis II Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Mucopolysaccharidosis II Sales Market Share by Application (2020-2025)
 Table 63. Global Mucopolysaccharidosis II Sales Market Share by Application (2026-2031)
 Table 64. Global Mucopolysaccharidosis II Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mucopolysaccharidosis II Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mucopolysaccharidosis II Revenue Market Share by Application (2020-2025)
 Table 67. Global Mucopolysaccharidosis II Revenue Market Share by Application (2026-2031)
 Table 68. Global Mucopolysaccharidosis II Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Mucopolysaccharidosis II Price (USD/Pcs) by Application (2026-2031)
 Table 70. Alexion Pharmaceuticals, Inc. Company Information
 Table 71. Alexion Pharmaceuticals, Inc. Description and Business Overview
 Table 72. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product
 Table 74. Alexion Pharmaceuticals, Inc. Recent Developments/Updates
 Table 75. AngioChem Inc. Company Information
 Table 76. AngioChem Inc. Description and Business Overview
 Table 77. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. AngioChem Inc. Mucopolysaccharidosis II Product
 Table 79. AngioChem Inc. Recent Developments/Updates
 Table 80. ArmaGen Inc. Company Information
 Table 81. ArmaGen Inc. Description and Business Overview
 Table 82. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. ArmaGen Inc. Mucopolysaccharidosis II Product
 Table 84. ArmaGen Inc. Recent Developments/Updates
 Table 85. Bioasis Technologies Inc. Company Information
 Table 86. Bioasis Technologies Inc. Description and Business Overview
 Table 87. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Bioasis Technologies Inc. Mucopolysaccharidosis II Product
 Table 89. Bioasis Technologies Inc. Recent Developments/Updates
 Table 90. Green Cross Corporation Company Information
 Table 91. Green Cross Corporation Description and Business Overview
 Table 92. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Green Cross Corporation Mucopolysaccharidosis II Product
 Table 94. Green Cross Corporation Recent Developments/Updates
 Table 95. Inventiva Company Information
 Table 96. Inventiva Description and Business Overview
 Table 97. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Inventiva Mucopolysaccharidosis II Product
 Table 99. Inventiva Recent Developments/Updates
 Table 100. JCR Pharmaceuticals Co., Ltd. Company Information
 Table 101. JCR Pharmaceuticals Co., Ltd. Description and Business Overview
 Table 102. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product
 Table 104. JCR Pharmaceuticals Co., Ltd. Recent Developments/Updates
 Table 105. Laboratorios Del Dr. Esteve S.A. Company Information
 Table 106. Laboratorios Del Dr. Esteve S.A. Description and Business Overview
 Table 107. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product
 Table 109. Laboratorios Del Dr. Esteve S.A. Recent Developments/Updates
 Table 110. RegenxBio Inc. Company Information
 Table 111. RegenxBio Inc. Description and Business Overview
 Table 112. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. RegenxBio Inc. Mucopolysaccharidosis II Product
 Table 114. RegenxBio Inc. Recent Developments/Updates
 Table 115. Sangamo BioSciences, Inc. Company Information
 Table 116. Sangamo BioSciences, Inc. Description and Business Overview
 Table 117. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product
 Table 119. Sangamo BioSciences, Inc. Recent Developments/Updates
 Table 120. Takeda Company Information
 Table 121. Takeda Description and Business Overview
 Table 122. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Takeda Mucopolysaccharidosis II Product
 Table 124. Takeda Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Mucopolysaccharidosis II Distributors List
 Table 128. Mucopolysaccharidosis II Customers List
 Table 129. Mucopolysaccharidosis II Market Trends
 Table 130. Mucopolysaccharidosis II Market Drivers
 Table 131. Mucopolysaccharidosis II Market Challenges
 Table 132. Mucopolysaccharidosis II Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mucopolysaccharidosis II
 Figure 2. Global Mucopolysaccharidosis II Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mucopolysaccharidosis II Market Share by Type: 2024 & 2031
 Figure 4. JR-141 Product Picture
 Figure 5. EGT-301 Product Picture
 Figure 6. DUOC-01 Product Picture
 Figure 7. AGT-182 Product Picture
 Figure 8. JR-032 Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Mucopolysaccharidosis II Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Mucopolysaccharidosis II Market Share by Application: 2024 & 2031
 Figure 12. Hospital
 Figure 13. Clinic
 Figure 14. Research Center
 Figure 15. Others
 Figure 16. Global Mucopolysaccharidosis II Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Mucopolysaccharidosis II Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Mucopolysaccharidosis II Sales (2020-2031) & (K Pcs)
 Figure 19. Global Mucopolysaccharidosis II Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Mucopolysaccharidosis II Report Years Considered
 Figure 21. Mucopolysaccharidosis II Sales Share by Manufacturers in 2024
 Figure 22. Global Mucopolysaccharidosis II Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Mucopolysaccharidosis II Players: Market Share by Revenue in Mucopolysaccharidosis II in 2024
 Figure 24. Mucopolysaccharidosis II Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Mucopolysaccharidosis II Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Mucopolysaccharidosis II Sales Market Share by Country (2020-2031)
 Figure 27. North America Mucopolysaccharidosis II Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Mucopolysaccharidosis II Sales Market Share by Country (2020-2031)
 Figure 31. Europe Mucopolysaccharidosis II Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Mucopolysaccharidosis II Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Mucopolysaccharidosis II Revenue Market Share by Region (2020-2031)
 Figure 39. China Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Mucopolysaccharidosis II Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Mucopolysaccharidosis II Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Mucopolysaccharidosis II Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Mucopolysaccharidosis II Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Mucopolysaccharidosis II Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Mucopolysaccharidosis II by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Mucopolysaccharidosis II by Type (2020-2031)
 Figure 61. Global Mucopolysaccharidosis II Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Mucopolysaccharidosis II by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Mucopolysaccharidosis II by Application (2020-2031)
 Figure 64. Global Mucopolysaccharidosis II Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Mucopolysaccharidosis II Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Mucopolysaccharidosis Type IVA Drug Market Research Report 2024
Global Mucopolysaccharidosis MPS Treatment Market Research Report 2024
Global Mucopolysaccharide Polysulphate Market Research Report 2025
Global Lysosomal Storage Disorder Drugs Market Research Report 2024
Morquio Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lysosomal Storage Disease Treatment Market Research Report 2024
Mucopolysaccharidosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
GM1 Gangliosidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genetic Disease Diagnostic Market Research Report 2025
Global Saccharification System Market Research Report 2025
Global Globoid Cell Leukodystrophy Treatment Market Research Report 2024
Mucopolysaccharidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Second generation Biofuels Market Research Report 2025
Global β galactosidase Market Research Report 2025
Global Sjogren s Syndrome Market Research Report 2025
Global Mucolipidosis II I Cell Disorder Market Research Report 2024
Global Myelodysplastic Syndrome Market Research Report 2024
Global Yeast Hydrolyzate Market Research Report 2025
Global Becker Muscular Dystropy Market Research Report 2025
Gaucher s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions